 |
|
Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions
Won-Il Choi
Precis Future Med. 2021;5(1):31-40. Published online 2021 Mar 2 DOI: https://doi.org/10.23838/pfm.2020.00205
|
|
Citations to this article as recorded by
 Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
Zijiao Zhang, Juhan Song, Seung-Hee Kwon, Zhao Wang, Suk-Gyun Park, Xianyu Piao, Je-Hwang Ryu, Nacksung Kim, Ok-Su Kim, Sun-Hun Kim, Jeong-Tae Koh
International Journal of Molecular Sciences.2023; 24(10): 8682. CrossRef Inhaled pulmonary surfactant biomimetic liposomes for reversing idiopathic pulmonary fibrosis through synergistic therapeutic strategy
Binghua Wang, Yiwen Gao, Lulu sun, Meng Xue, Mingjin Wang, Zhenzhong Zhang, Lirong Zhang, Hongling Zhang
Biomaterials.2023; 303: 122404. CrossRef
|